Table 2.
The entrapment efficiency%, particle size, zeta potential, and the polydispersity index of the prepared carbamazepine solid lipid nanoparticles formulations.
| Formulation No. | Entrapment Efficiency% EE (%) | Particle Size (nm) | Zeta Potential (mv) | Polydispersity Index (PDI) |
|---|---|---|---|---|
| F1 | 39.66 ± 2.42 | 760.7 ± 5.25 | −25.1 ± 0.98 | 0.234 ± 0.08 |
| F2 | 51.22 ± 1.28 | 691.1 ± 9.02 | −27.6 ± 0.75 | 0.196 ± 0.05 |
| F3 | 58.16 ± 1.15 | 648.7 ± 11.54 | −27.7 ± 0.85 | 0.277 ± 0.01 |
| F4 | 61.49 ± 0.85 | 626.5 ± 7.25 | −21.5 ± 1.02 | 0.217 ± 0.04 |
| F5 | 62.08 ± 1.05 | 177.8 ± 6.24 | −32.5 ± 1.14 | 0.394 ± 0.07 |
| F6 | 63.95 ± 0.89 | 165.0 ± 8.21 | −38.4 ± 1.32 | 0.419 ± 0.02 |
| F7 | 68.88 ± 0.37 | 63.30 ± 8.27 | −30.1 ± 0.58 | 0.318 ± 0.04 |
| F8 | 71.91 ± 1.20 | 45.11 ± 6.72 | −33.3 ± 1.45 | 0.277 ± 0.03 |